The Medical Debt Mitigation Amendment Act would substantially change how medical debt is handled in the District of Columbia, with a focus on preventing aggressive collection practices and requiring more upfront financial assistance screening by health care facilities. The bill directs the Department of Health to collect annual data from covered facilities on financial assistance policies, patient demographics, outstanding bills, debt sales, and litigation activity, and it ties good standing for certificate-of-need purposes to maintaining a compliant financial assistance policy.
The bill requires health care facilities with financial assistance policies to offer free or discounted care to eligible patients, provide good-faith cost estimates, screen certain patients for assistance, and allow applications for up to 240 days after the first bill. It also sets minimum assistance levels based on income, requires payment plans for eligible patients, and limits when collection actions can begin. In addition, it prohibits reporting medical debt to credit bureaus, restricts wage garnishments and property liens, bars revival of judgments for medical debt, and limits interest on medical debt. The bill also restricts health care providers from helping market or complete applications for medical lending products in certain circumstances and makes violations of those restrictions an unfair or deceptive trade practice.
The bill would amend several parts of D.C. law, including the Health Services Planning Program Re-establishment Act, consumer protection provisions in Title 28, hospital lien law in Title 40, and judgment revival rules in Title 15. It would create new statutory definitions for medical debt, medical lending products, collection entities, and health care facility-FAPs, and it would establish new enforcement and complaint procedures through the Department of Health and the Office of the Attorney General. The practical effect would be to expand patient protections, impose new reporting and compliance obligations on hospitals and other covered providers, and limit the tools available to collectors and creditors.
The general sentiment reflected in the voting history appears strongly supportive: the bill passed first reading by a 12-0 vote. No committee transcript excerpts were provided, so there is no recorded debate to indicate broader disagreement in the available materials. The unanimous vote suggests broad Council support for the bill’s consumer-protection and medical-debt-relief goals.
The main points of contention inherent in the bill are likely to be the compliance burden on health care facilities, the limits on collection remedies, and the restrictions on medical lending products. Providers and collectors may view the bill as reducing their ability to recover unpaid balances, while patient advocates would likely support the stronger screening, payment-plan, and anti-collection protections. The bill also raises operational issues around reporting, rulemaking, and coordination with insurance appeals, but no specific opposition is documented in the provided context.
The bill would amend multiple sections of the D.C. Code to create a comprehensive medical debt mitigation framework. It would require certain health care facilities to adopt and publicize financial assistance policies, report detailed annual data to the Department of Health, offer payment plans to eligible patients, and comply with new screening and notice requirements. It would also prohibit or limit several debt-collection practices, including credit reporting of medical debt, wage garnishment for lower-income households, property liens on primary residences, revival of judgments for medical debt, and certain collection actions while insurance appeals are pending. The bill further adds consumer-protection restrictions on medical lending products and makes violations an unfair or deceptive trade practice.
The available voting record indicates strong support for the bill, as it passed first reading unanimously, 12-0. No committee transcript excerpts were provided, so there is no direct record of floor or committee debate. Based on the text and the vote, the bill appears to have been received as a patient-protection measure aimed at reducing medical debt burdens and improving access to financial assistance.
The likely areas of contention are the bill’s limits on collection and creditor remedies, the mandatory financial-assistance and reporting obligations imposed on health care facilities, and the restrictions on medical lending products. Hospitals, debt collectors, and lenders may object to the administrative costs and reduced recovery options, while patient advocates would likely favor the stronger protections and screening requirements. The bill also could raise implementation concerns about rulemaking, data collection, and coordination with insurance appeals, but no specific objections are documented in the provided materials.